arrow
C

Christian Grommes

Memorial Sloan Kettering Cancer Center
H指数:37
被引数:8,504

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment

新诊断胶质母细胞瘤伴显著功能损害患者住院化放疗的结局

2026-01-010
OA
PHASE IB STUDY OF COPANLISIB, A PAN PI3K INHIBITOR, IN COMBINATION WITH IBRUTINIB, A BTK INHIBITOR, IN RELAPSED OR REFRACTORY PRIMARY CNS LYMPHOMA

I期B研究:评估泛PI3K抑制剂copanlisib与BTK抑制剂ibrutinib联合治疗复发或难治性原发性中枢神经系统淋巴瘤的疗效。

2025-11-010
OAAI
ANALYSIS OF GENETIC MUTATION PROFILE AND CNS PHARMACOKINETICS IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA PATIENTS RESPONDING TO NOVEL EMAVUSERTIB (IRAK4I) AND BTKI COMBINATION

复发/难治性原发性中枢神经系统淋巴瘤患者对新型EMAVUSERTIB(IRAK4I)和BTKI联合治疗反应的遗传突变谱和中枢神经系统药代动力学分析

2025-11-010
OAAI
Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residents

神经肿瘤学在美国神经病学部门的代表性:对大查房的分析以及教职员工和住院医师的观点

2025-10-010
PRE
Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma

多中心篮式试验针对中枢神经系统肿瘤,确定了CDK4/6抑制剂abemaciclib在复发性脑膜瘤中的活性

2025-10-010
PRE
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma

Ib期研究:在复发/难治性中枢神经系统淋巴瘤患者中扩大伊布替尼、来那度胺和利妥昔单抗的应用

2025-06-010
PRE
CENTRAL NERVOUS SYSTEM BRIDGING RADIOTHERAPY (CNS-BRT) ACHIEVES RAPID CYTOREDUCTION PRIOR TO CAR T-CELL THERAPY FOR AGGRESSIVE B-CELL LYMPHOMAS

中枢神经系统桥接放疗 (cns-brt) 在CAR T细胞治疗侵袭性b细胞淋巴瘤之前实现了快速的细胞减少

2024-11-110
PRE
Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Combination with Ibrutinib in Relapsed/Refractory Primary Central Nervous System Lymphoma Patients with Prior Exposure to BTK Inhibitor

初步评估Emavusertib (CA-4948)联合Ibrutinib在既往接受过BTK抑制剂治疗的原发性中枢神经系统淋巴瘤复发/难治性患者中的安全性与有效性

BLOOD
IF23.1
2024-11-051
PRE
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma

巩固治疗方案及原发性中枢神经系统淋巴瘤患者的脑萎缩

2024-11-011
PRE
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas

CNS桥接放疗在CAR T细胞治疗侵袭性b细胞淋巴瘤之前实现了快速的细胞减少

2024-10-084
OAAI
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma
2024-07-122
PRE
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review

液体活检可改善CNS淋巴瘤的诊断和监测: RANO综述

2024-04-106
OA